FOLLOWING ECIL 1
The first European Conference on infections in leukaemia: Why and how?
C. Cordonnier, T Calandra.
Eur J Cancer 2007; Suppl. 5, 2-4.
Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients
G Bucaneve, E Castagnola, C Viscoli, L Leibovici, F Menichetti
Eur J Cancer 2007; Suppl. 5, 5-12.
The need for aminoglycosides in combination with betalactams for high-risk, febrile neutropaenic patients with leukaemia
L Drgona, M Paul, G Bucaneve, T Calandra, F Menichetti
Eur J Cancer 2007; Suppl. 5. 13-22
Empirical use of anti-Gram-positive antibiotics in febrile
neutropaenic cancer patients with acute leukaemia 5
Alain Cometta*, O. Marchetti, T. Calandra
Eur J Cancer 2007; Suppl. 5. 23-31
Primary antifungal prophylaxis in leukaemia patients.
J Maertens, P Frere, C Lass-Flörl, W Heinz, OA Cornely.
Eur J Cancer 2007;Suppl.5:43-8.
Empirical antifungal therapy in neutropenic cancer patients with persistent fever. Guidelines of the ECIL1 conference.
O Marchetti, C Cordonnier, T Calandra.
Eur J Cancer 2007; Suppl. 5. 32-42.
European guidelines for the treatment of invasive candida and invasive aspergillus infections in adult haematological patients.
R Herbrecht, U Fluckiger, B Gachot, P Ribaud, A Thiebaut, C Cordonnier.
Eur J Cancer 2007; Suppl. 5., 49-59.
